AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

AI startup ByteBrain is transforming clinical trials with agent-based optimization, cutting costs, boosting efficiency, and ...

IQVIA’s new AI orchestrator agents — powered by IQVIA Connected Intelligence and NVIDIA AI Foundry — speed clinical trials ...

There’s no shortage of big promises about AI in healthcare. The U.S. government announced a $500 billion Stargate initiative ...

Prestigious international annual awards program recognizes standout digital health and medical technology products and ...

Industry experts gathered at the Outsourcing in Clinical Trials East Coast 2025 conference to discuss artificial intelligence ...

The technology’s potential to transform trials will need to be balanced with the challenge of instilling trust in ...

AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...

Researchers at the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology, in ...

During a panel discussion on AI in clinical research, Prasanna Rao, Chief Products and Innovation officer at Saama emphasised the importance of making protocol data available to large language ...

The landscape of clinical trials is rapidly transforming. As we move through 2025, smarter technologies and patient-centric ...

In this issue: assessing the regulators' role as AI in clinical trials evolves, the potential for a newborn screening refresh ...